Author: Dee L. Mahoney
In my last post, I shared that at the beginning of 2011, there were 885 healthcare qui tam cases under investigation. 180 of those cases allege that some pharmaceutical and device manufacturers are committing fraud in connection with the pricing and marketing of their products. Each of these investigations may require the manufacturers involved to divulge their emails and internal business communications to the Department of Justice. Continue reading